Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Porcine Neurotrophin 3 ELISA Kit (AC3337)
Cat.#: ASET-1926
Specifications
Description Porcine Neurotrophin 3 ELISA Kit allows for the in vitro quantitative determination of porcine Neurotrophin 3 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Porcine Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 18.75 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 31.25-2000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2240 Human RKIP ELISA Kit (AC3651) Quantitative inquiry ASET-1682 Human Somatostatin ELISA Kit (AC3093) Quantitative inquiry ASET-1631 Rabbit eNOS ELISA Kit (AC3042) Quantitative inquiry ASET-2258 Human CBLN2 ELISA Kit (AC3669) Quantitative inquiry ASET-1757 Human Axin 2 ELISA Kit (AC3168) Quantitative inquiry ASET-1823 Human FGFR2 ELISA Kit (AC3234) Quantitative inquiry ASET-1852 Mouse Thrombospondin 1 ELISA Kit (AC3263) Quantitative inquiry ASET-1967 Human Estrogen Receptor beta ELISA Kit (AC3378) Quantitative inquiry ASET-2022 Human NOTCH3 ELISA Kit (AC3433) Quantitative inquiry ASET-2084 Mouse PEDF ELISA Kit (AC3495) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket